Skip to main content
Caplight Logo









Bilihome B.V.

Bilihome B.V.

Private
NijkerkHealthcare & Life Scienceshttps://bilihome.org/

Last Round

Crowdfunding

Jul 16, 2025

Est. Valuation

$12.04M

Total Funding Raised

$2.69M

Company Overview

Bilihome B.V. is a medical technology company that develops wearable phototherapy solutions for the treatment of neonatal jaundice.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Health IoT, Patient Engagement

Business Model

B2B

Customer Profile

Hardware Sales, Subscription SaaS, Services & Consulting

AI Layer

Non-AI

Keywords

neonatal jaundice treatmentphototherapywearable medical deviceNICU technologyhome phototherapyneonatal careremote patient monitoringRPMmedtechzero separation carebaby jaundiceblue light therapyclinical care pathwaymaternity care

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bilihome B.V. Comparables

Compare Bilihome B.V. with similar companies based on industry and business-model similarity.

Bilihome B.V. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Little Sparrows Technologies
86%
NeoMedLight
84%
NeoLight
79%

Bilihome B.V. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
CrowdfundingJul 16, 2025
Early FundingJan 14, 2022

Key People

Founding team and executive leadership

Margret Huenerbein

Chief Executive Officer

Executive Team

Bilihome B.V. Investors

Notable investors and investment history

Bilihome B.V. investors
InvestorRounds
NLC Health VenturesCrowdfunding
East Netherlands Development Agency (Oost NL)Early Funding, Crowdfunding
Health InnovationsEarly Funding, Crowdfunding

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 14, 2022

    Secured funding from Health Innovations and Oost NL.

Bilihome B.V. Filings

Explore SEC and related filing metadata, where available.

Bilihome B.V. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Bilihome B.V.'s valuation, stock price, and market status.

Is Bilihome B.V. a public or private company?

Bilihome B.V. is a private company.

What is the current stock price of Bilihome B.V.?

Bilihome B.V. is a private company with no public stock price. Caplight tracks Bilihome B.V.'s secondary market activity and provides MarketPrice estimates to Caplight users.

How much is Bilihome B.V. worth (valuation)?

Bilihome B.V.'s valuation is estimated at $12.0M based on funding round data.

Can I buy Bilihome B.V. stock?

Bilihome B.V. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Bilihome B.V.'s last funding round?

Bilihome B.V.'s most recent funding round was Crowdfunding on July 16, 2025.

Who are the main investors in Bilihome B.V.?

Key investors in Bilihome B.V. include NLC Health Ventures, East Netherlands Development Agency (Oost NL), Health Innovations.

Will Bilihome B.V. IPO soon?

No public IPO plans have been announced for Bilihome B.V..

How can I track Bilihome B.V. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Bilihome B.V.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersNijkerk
Employee Range9
Year Founded2019
Last FundingJul 16, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?